Investigating immune responses related to neurological issues from COVID-19
Humoral Immune Mechanisms of Acute and Chronic Neurologic Sequelae of COVID-19
This study is looking at how COVID-19 might cause brain and nerve problems, like encephalitis and Guillain-Barré syndrome, and aims to find specific markers in patients that could help doctors better understand and treat these issues.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10992116 on NIH RePORTER |
What this research studies
This research focuses on understanding the immune mechanisms behind neurological complications that arise from COVID-19, such as encephalitis and Guillain-Barré syndrome. The team at UCSF aims to identify specific biomarkers that indicate autoimmune responses triggered by the virus, which could help in managing these conditions more effectively. By analyzing patient samples, they will explore the relationship between the virus and neurological symptoms, providing insights into potential treatments. The study involves a cohort of patients with suspected neuroinflammatory diseases, allowing for a comprehensive approach to understanding these complex conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals of all ages who have experienced neurological symptoms following a COVID-19 infection.
Not a fit: Patients who have not had COVID-19 or do not exhibit neurological symptoms related to the virus may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnosis and treatment options for patients experiencing neurological complications from COVID-19.
How similar studies have performed: Other research has shown promise in identifying autoimmune responses related to viral infections, suggesting that this approach could yield valuable insights.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Wilson, Michael R — University of California, San Francisco
- Study coordinator: Wilson, Michael R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.